Hemophilia A Drug Market

List of Tables
Table 1. Hemophilia A Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Hemophilia A Drug Market Trends
Table 3. Hemophilia A Drug Market Drivers
Table 4. Hemophilia A Drug Market Challenges
Table 5. Hemophilia A Drug Market Restraints
Table 6. Global Hemophilia A Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Hemophilia A Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Hemophilia A Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Hemophilia A Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Hemophilia A Drug Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Hemophilia A Drug Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Hemophilia A Drug Revenue Share by Manufacturer, 2017-2022
Table 13. Global Hemophilia A Drug Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Hemophilia A Drug Sales Share by Manufacturer, 2017-2022
Table 15. Global Hemophilia A Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Hemophilia A Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A Drug as of 2021)
Table 18. Top Players of Hemophilia A Drug in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Hemophilia A Drug Product Type
Table 20. Date of International Manufacturers Enter into Hemophilia A Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Hemophilia A Drug Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Hemophilia A Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Hemophilia A Drug Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Hemophilia A Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Hemophilia A Drug Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Hemophilia A Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Hemophilia A Drug Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Hemophilia A Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Hemophilia A Drug Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Hemophilia A Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Hemophilia A Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Hemophilia A Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Hemophilia A Drug Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Hemophilia A Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Hemophilia A Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Hemophilia A Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Hemophilia A Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Hemophilia A Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Hemophilia A Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Hemophilia A Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Bayer AG Corporation Information
Table 43. Bayer AG Description and Business Overview
Table 44. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Bayer AG Hemophilia A Drug Product
Table 46. Bayer AG Recent Development
Table 47. BioMarin Pharmaceutical Inc Corporation Information
Table 48. BioMarin Pharmaceutical Inc Description and Business Overview
Table 49. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. BioMarin Pharmaceutical Inc Product
Table 51. BioMarin Pharmaceutical Inc Recent Development
Table 52. Bioverativ Inc Corporation Information
Table 53. Bioverativ Inc Description and Business Overview
Table 54. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Bioverativ Inc Product
Table 56. Bioverativ Inc Recent Development
Table 57. Catalyst Biosciences Inc Corporation Information
Table 58. Catalyst Biosciences Inc Description and Business Overview
Table 59. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Catalyst Biosciences Inc Product
Table 61. Catalyst Biosciences Inc Recent Development
Table 62. Chugai Pharmaceutical Co Ltd Corporation Information
Table 63. Chugai Pharmaceutical Co Ltd Description and Business Overview
Table 64. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Chugai Pharmaceutical Co Ltd Product
Table 66. Chugai Pharmaceutical Co Ltd Recent Development
Table 67. CSL Ltd Corporation Information
Table 68. CSL Ltd Description and Business Overview
Table 69. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. CSL Ltd Product
Table 71. CSL Ltd Recent Development
Table 72. DBV Technologies SA Corporation Information
Table 73. DBV Technologies SA Description and Business Overview
Table 74. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. DBV Technologies SA Product
Table 76. DBV Technologies SA Recent Development
Table 77. Dimension Therapeutics Inc Corporation Information
Table 78. Dimension Therapeutics Inc Description and Business Overview
Table 79. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Dimension Therapeutics Inc Product
Table 81. Dimension Therapeutics Inc Recent Development
Table 82. EpiVax Inc Corporation Information
Table 83. EpiVax Inc Description and Business Overview
Table 84. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. EpiVax Inc Product
Table 86. EpiVax Inc Recent Development
Table 87. Expression Therapeutics LLC Corporation Information
Table 88. Expression Therapeutics LLC Description and Business Overview
Table 89. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Expression Therapeutics LLC Product
Table 91. Expression Therapeutics LLC Recent Development
Table 92. Green Cross Corp Corporation Information
Table 93. Green Cross Corp Description and Business Overview
Table 94. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Green Cross Corp Product
Table 96. Green Cross Corp Recent Development
Table 97. Idogen AB Corporation Information
Table 98. Idogen AB Description and Business Overview
Table 99. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Idogen AB Product
Table 101. Idogen AB Recent Development
Table 102. Immusoft Corp Corporation Information
Table 103. Immusoft Corp Description and Business Overview
Table 104. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Immusoft Corp Product
Table 106. Immusoft Corp Recent Development
Table 107. LFB SA Corporation Information
Table 108. LFB SA Description and Business Overview
Table 109. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. LFB SA Product
Table 111. LFB SA Recent Development
Table 112. mAbxience SA Corporation Information
Table 113. mAbxience SA Description and Business Overview
Table 114. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. mAbxience SA Product
Table 116. mAbxience SA Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Hemophilia A Drug Customers List
Table 120. Hemophilia A Drug Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia A Drug Product Picture
Figure 2. Global Hemophilia A Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Hemophilia A Drug Market Size 2017-2028 (US$ Million)
Figure 4. Global Hemophilia A Drug Sales 2017-2028 (K Pcs)
Figure 5. United States Hemophilia A Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Hemophilia A Drug Market Size 2017-2028 (US$ Million)
Figure 7. United States Hemophilia A Drug Sales 2017-2028 (K Pcs)
Figure 8. United States Hemophilia A Drug Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Hemophilia A Drug Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Hemophilia A Drug Report Years Considered
Figure 11. Product Picture of ATXF-8117
Figure 12. Product Picture of BAY-1093884
Figure 13. Product Picture of BIVV-001
Figure 14. Product Picture of BS-027125
Figure 15. Product Picture of Concizumab
Figure 16. Product Picture of CSL-689
Figure 17. Product Picture of Others
Figure 18. Global Hemophilia A Drug Market Share by Type in 2022 & 2028
Figure 19. Global Hemophilia A Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 20. Global Hemophilia A Drug Sales Market Share in Value by Type (2017-2028)
Figure 21. Global Hemophilia A Drug Sales by Type (2017-2028) & (K Pcs)
Figure 22. Global Hemophilia A Drug Sales Market Share in Volume by Type (2017-2028)
Figure 23. Global Hemophilia A Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 24. United States Hemophilia A Drug Market Share by Type in 2022 & 2028
Figure 25. United States Hemophilia A Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 26. United States Hemophilia A Drug Sales Market Share in Value by Type (2017-2028)
Figure 27. United States Hemophilia A Drug Sales by Type (2017-2028) & (K Pcs)
Figure 28. United States Hemophilia A Drug Sales Market Share in Volume by Type (2017-2028)
Figure 29. United States Hemophilia A Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 30. Product Picture of Clinic
Figure 31. Product Picture of Hospital
Figure 32. Product Picture of ASCs
Figure 33. Global Hemophilia A Drug Market Share by Application in 2022 & 2028
Figure 34. Global Hemophilia A Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. Global Hemophilia A Drug Sales Market Share in Value by Application (2017-2028)
Figure 36. Global Hemophilia A Drug Sales by Application (2017-2028) & (K Pcs)
Figure 37. Global Hemophilia A Drug Sales Market Share in Volume by Application (2017-2028)
Figure 38. Global Hemophilia A Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 39. United States Hemophilia A Drug Market Share by Application in 2022 & 2028
Figure 40. United States Hemophilia A Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 41. United States Hemophilia A Drug Sales Market Share in Value by Application (2017-2028)
Figure 42. United States Hemophilia A Drug Sales by Application (2017-2028) & (K Pcs)
Figure 43. United States Hemophilia A Drug Sales Market Share in Volume by Application (2017-2028)
Figure 44. United States Hemophilia A Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 45. North America Hemophilia A Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. North America Hemophilia A Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. U.S. Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Canada Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Europe Hemophilia A Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 50. Europe Hemophilia A Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. Germany Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. France Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.K. Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Italy Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Russia Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Asia-Pacific Hemophilia A Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 57. Asia-Pacific Hemophilia A Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 58. China Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Japan Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. South Korea Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. India Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Australia Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Taiwan Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Indonesia Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Thailand Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Malaysia Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Philippines Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Latin America Hemophilia A Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Latin America Hemophilia A Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Mexico Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Brazil Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Argentina Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Middle East & Africa Hemophilia A Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 74. Middle East & Africa Hemophilia A Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 75. Turkey Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. UAE Hemophilia A Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Hemophilia A Drug Value Chain
Figure 79. Hemophilia A Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed